UnitedHealth/Emis: After Remedy Rejected, Unconditional Clearance Becomes Best Option For Salvaging Deal

UnitedHealth Group (UNH) will probably need the Competition and Markets Authority’s unconditional clearance for its planned 1.2 billion pound ($1.5 billion) acquisition of health care software and systems provider Emis Group (EMIS: LN) after the UK regulator rejected the company’s far-reaching remedy proposal, according to a Capitol Forum analysis. Hoping to overturn CMA’s phase 1 […]

Publishers Urge EU to Take ‘Immediate’ Measures to Tackle Meta Scam Ads Under Digital Rules

European publishers are urging EU officials to act quickly to force Meta (META) to stop the proliferation of fraudulent advertisements impersonating reporters and media outlets across its platforms...

Apr 22, 2026 Read Now >

House Judiciary Panel Counsel Cella, Paul Hastings Partner Murray Emerge as Early Contenders to Become DOJ Antitrust Head

Adam Cella, a senior House GOP counsel, and Michael Murray, who served at DOJ during President Donald Trump’s first term, have emerged as early contenders to take over the department’s antitrust...

Apr 20, 2026 Read Now >

JD.com/Ceconomy: JD.com Set to File EU Foreign Subsidies Notification Shortly for Ceconomy Takeover, Sources Say

China’s e-commerce group JD.com (9618: HK) plans to file a notification shortly under the EU’s Foreign Subsidies Regulation (FSR) of its takeover bid for Germany’s electronics retailer Ceconomy...

Apr 20, 2026 Read Now >

UnitedHealth/Emis: After Remedy Rejected, Unconditional Clearance Becomes Best Option For Salvaging Deal

RELATED ARTICLES | Editor’s picks

Publishers Urge EU to Take ‘Immediate’ Measures to Tackle Meta Scam Ads Under Digital Rules

House Judiciary Panel Counsel Cella, Paul Hastings Partner Murray Emerge as Early Contenders to Become DOJ Antitrust Head

JD.com/Ceconomy: JD.com Set to File EU Foreign Subsidies Notification Shortly for Ceconomy Takeover, Sources Say

FILTER BY

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.